Mustonen H - Search Results

1

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread.

Vesterinen T, Kuopio T, Ahtiainen M, Knuuttila A, Mustonen H, Salmenkivi K, Arola J, Haglund C. Vesterinen T, et al. Among authors: mustonen h. Endocr Connect. 2019 Aug 1;8(8):1168-1175. doi: 10.1530/EC-19-0308. Endocr Connect. 2019. PMID: 31299636 Free PMC article.

2

Podocalyxin is a marker of poor prognosis in colorectal cancer.

Kaprio T, Fermér C, Hagström J, Mustonen H, Böckelman C, Nilsson O, Haglund C. Kaprio T, et al. Among authors: mustonen h. BMC Cancer. 2014 Jul 8;14:493. doi: 10.1186/1471-2407-14-493. BMC Cancer. 2014. PMID: 25004863 Free PMC article.

3

A comparative study of two PODXL antibodies in 840 colorectal cancer patients.

Kaprio T, Hagström J, Fermér C, Mustonen H, Böckelman C, Nilsson O, Haglund C. Kaprio T, et al. Among authors: mustonen h. BMC Cancer. 2014 Jul 8;14:494. doi: 10.1186/1471-2407-14-494. BMC Cancer. 2014. PMID: 25004935 Free PMC article.

4

REG4 independently predicts better prognosis in non-mucinous colorectal cancer.

Kaprio T, Hagström J, Mustonen H, Koskensalo S, Andersson LC, Haglund C. Kaprio T, et al. Among authors: mustonen h. PLoS One. 2014 Oct 8;9(10):e109600. doi: 10.1371/journal.pone.0109600. eCollection 2014. PLoS One. 2014. PMID: 25295732 Free PMC article.

5

N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.

Kaprio T, Satomaa T, Heiskanen A, Hokke CH, Deelder AM, Mustonen H, Hagström J, Carpen O, Saarinen J, Haglund C. Kaprio T, et al. Among authors: mustonen h. Mol Cell Proteomics. 2015 Feb;14(2):277-88. doi: 10.1074/mcp.M114.041632. Epub 2014 Dec 1. Mol Cell Proteomics. 2015. PMID: 25452313 Free PMC article.

6

Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.

Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, Arola J. Pennanen M, et al. Among authors: mustonen h. Hum Pathol. 2015 Mar;46(3):404-10. doi: 10.1016/j.humpath.2014.11.015. Epub 2014 Dec 9. Hum Pathol. 2015. PMID: 25582500

7

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Saukkonen K, Hagström J, Mustonen H, Juuti A, Nordling S, Fermér C, Nilsson O, Seppänen H, Haglund C. Saukkonen K, et al. Among authors: mustonen h. PLoS One. 2015 Jun 8;10(6):e0129012. doi: 10.1371/journal.pone.0129012. eCollection 2015. PLoS One. 2015. PMID: 26053486 Free PMC article.

8

Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.

Boyd S, Tenca A, Jokelainen K, Mustonen H, Krogerus L, Arola J, Färkkilä MA. Boyd S, et al. Among authors: mustonen h. Endoscopy. 2016 May;48(5):432-9. doi: 10.1055/s-0041-110792. Epub 2016 Jan 25. Endoscopy. 2016. PMID: 26808393

9

The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.

Seppänen H, Juuti A, Mustonen H, Haapamäki C, Nordling S, Carpelan-Holmström M, Sirén J, Luettges J, Haglund C, Kiviluoto T. Seppänen H, et al. Among authors: mustonen h. Scand J Surg. 2017 Mar;106(1):54-61. doi: 10.1177/1457496916645963. Epub 2016 Jun 23. Scand J Surg. 2017. PMID: 27130378

10

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.

Saukkonen K, Hagström J, Mustonen H, Juuti A, Nordling S, Kallio P, Alitalo K, Seppänen H, Haglund C. Saukkonen K, et al. Among authors: mustonen h. BMC Cancer. 2016 Jul 13;16:472. doi: 10.1186/s12885-016-2497-5. BMC Cancer. 2016. PMID: 27411302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters